Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for vascular disease, has announced its participation in the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 at 4:00pm EST at the Lotte New York Palace Hotel, 4th Floor Holmes II.
CEO Andy Doraiswamy will discuss the company’s latest clinical research, strategic growth plans, commercialization progress of its products including Dayspring® non-pneumatic compression for chronic edema, and pipeline for comprehensive vascular solutions across the care continuum.
Conference attendees can engage with Koya through one-on-one networking sessions to learn more.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases—serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health—high lighting the urgent need for modern, evidence-based, and scalable solutions.
